Increased VIP levels in peripheral blood outside migraine attacks as a potential biomarker of cranial parasympathetic activation in chronic migraine

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Cephalalgia

• Publication date

  2015-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/0333102414535111PMID 24847167
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sphenopalatine ganglion neuromodulation in migraine: What is the rationale?

  2014cited by this paper
• Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine

  2013cited by this paper
• The International Classification of Headache Disorders, 3rd edition (beta version)

  2013cited by this paper
• Autonomic nervous system control of the cerebral circulation.

  2013influential reference
• Cranial autonomic symptoms in pediatric migraine are the rule, not the exception

  2013cited by this paper
• Unilateral cranial autonomic symptoms in patients with migraine

  2012cited by this paper
• Diencephalic and brainstem mechanisms in migraine

  2011cited by this paper
• Cutaneous nociception and neurogenic inflammation evoked by PACAP38 and VIP

  2010influential reference
• Cranial autonomic symptoms in migraine: characteristics and comparison with cluster headache

  2010cited by this paper
• Activation of Meningeal Nociceptors by Cortical Spreading Depression: Implications for Migraine with Aura

  2010cited by this paper
• The role of peptides in central sensitization.

  2009influential reference
• Vasoactive Intestinal Peptide Causes Marked Cephalic Vasodilation, but does not Induce Migraine

  2008cited by this paper
• The International Classification of Headache Disorders

  2008cited by this paper
• Cranial autonomic symptoms in migraine: characteristics and comparison with cluster headache

  2008cited by this paper
• A Report of Cranial Autonomic Symptoms in Migraineurs

  2007cited by this paper
• Prevalence of Trigeminal Autonomic Symptoms in Migraine: A Population-Based Study

  2007cited by this paper
• Salivary Levels of CGRP and VIP in Rhinosinusitis and Migraine Patients

  2006cited by this paper
• Clinical-Biochemical Correlates of Migraine Attacks in Rizatriptan Responders and Non-Responders

  2006cited by this paper
• Vasoactive Intestinal Polypeptide Evokes Only a Minimal Headache in Healthy Volunteers

  2006cited by this paper
• Unitary hypothesis for multiple triggers of the pain and strain of migraine

  2005cited by this paper
• Neurobiology in primary headaches.

  2005influential reference
• Autonomic asymmetry in migraine: augmented parasympathetic activation in left unilateral migraineurs.

  2004cited by this paper
• Different patterns of parasympathetic activation in uni- and bilateral migraineurs.

  2003cited by this paper
• 2003 Wolff Award: Possible Parasympathetic Contributions to Peripheral and Central Sensitization During Migraine

  2003cited by this paper
• Unilateral Cranial Autonomic Symptoms in Migraine

  2002cited by this paper
• Unilateral Cranial Autonomic Symptoms in Migraine

  2002cited by this paper
• Sensitization of meningeal sensory neurons and the origin of headaches

  1996influential reference
• The trigeminovascular system and migraine: Studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats

  1993cited by this paper
• Vasoactive peptide release in the extracerebral circulation of humans during migraine headache

  1990cited by this paper
• Distribution and dilatory effect of vasoactive intestinal polypeptide (VIP) in human cerebral arteries.

  1984cited by this paper

• Meningeal neuropeptide and neuroimmune interactions in the context of migraine.

  2026cites this paper
• Preoperative and Postoperative Plasma Levels of Neuroinflammatory Neuropeptides in the Patients with Lumbar Disc Herniation

  2025cites this paper
• Migraine: symptoms, types, pathophysiology and diagnosis.

  2025cites this paper
• Biomarkers in headaches as a potential solution to simplify differential diagnosis of primary headache disorders: a systematic review

  2025cites this paper
• Differences in Neuropathology between Nitroglycerin-Induced Mouse Models of Episodic and Chronic Migraine

  2024cites this paper
• The Role of Biomarkers Pituitary Adenylate Cyclase‐Activating Polypeptide (PACAP) and Vasoactive Intestinal Peptide (VIP) in Chronic and Episodic Migraines: A Meta‐Analysis

  2024influential citation
• Biochemical aspects of migraine pathogenesis

  2024cites this paper
• Cardiovascular autonomic reactivity and inflammatory markers in patients with chronic migraine

  2024cites this paper
• Medication “underuse” headache

  2024cites this paper
• Reconceptualizing autonomic function testing in migraine: a systematic review and meta-analysis

  2024cites this paper
• Molecular and Cellular Neurobiology of Circadian and Circannual Rhythms in Migraine: A Narrative Review

  2023cites this paper
• From CGRP to PACAP, VIP, and Beyond: Unraveling the Next Chapters in Migraine Treatment

  2023influential citation
• Calcitonin gene-related peptide (CGRP) concentrations outside migraine attacks in peripheral blood as a potential biomarker for chronic migraine

  2023cites this paper
• Serological Biomarkers of Chronic Migraine

  2023cites this paper
• Migraine Treatment: Towards New Pharmacological Targets

  2023cites this paper
• Molecular Mechanisms of Migraine: Nitric Oxide Synthase and Neuropeptides

  2023cites this paper
• Future targets for migraine treatment beyond CGRP

  2023cites this paper
• The Function of the Autonomic Nervous System in Asian Patients With Chronic Migraine

  2022cites this paper
• Therapeutic applications and potential mechanisms of acupuncture in migraine: A literature review and perspectives

  2022cites this paper
• Pathophysiology of Chronic Migraine: Insights from Recent Neuroimaging Research

  2022cites this paper
• The 15‐day threshold in the definition of chronic migraine is reasonable and sufficient—Five reasons for not changing the ICHD‐3 definition

  2022cites this paper
• Recently approved and emerging drug options for migraine prophylaxis

  2022influential citation
• Treatment of migraine with monoclonal antibodies

  2022cites this paper
• The Role of Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide in Migraine Pathogenesis

  2022cites this paper
• Migraine with Brainstem Aura Accompanied by Disorders of Consciousness

  2021cites this paper
• Evaluation of Serum Levels of Transient Receptor Potential Cation Channel Subfamily V Member 1, Vasoactive Intestinal Polypeptide, and Pituitary Adenylate Cyclase-Activating Polypeptide in Chronic and Episodic Migraine: The Possible Role in Migraine Transformation

  2021cites this paper
• Expression of Selected microRNAs in Migraine: A New Class of Possible Biomarkers of Disease?

  2021cites this paper
• Metabolic profile changes in serum of migraine patients detected using 1H-NMR spectroscopy

  2021cites this paper
• Cranial autonomic symptoms: prevalence, phenotype and laterality in migraine and two potentially new symptoms

  2021cites this paper
• Chronic Migraine Pathophysiology and Treatment: A Review of Current Perspectives

  2021cites this paper
• Calcitonin gene-related peptide in migraine: from pathophysiology to treatment.

  2021cites this paper
• Heart Rate Variability Analysis in Episodic Migraine: A Cross-Sectional Study

  2021cites this paper
• Peripheral, Interictal Serum S100B Levels are Not Increased in Chronic Migraine Patients.

  2020cites this paper
• The Chronic Migraine Brain: What Have We Learned From Neuroimaging?

  2020cites this paper
• Chronic Migraine in Adolescence

  2020cites this paper
• Serotonin and Neuropeptides in Blood From Episodic and Chronic Migraine and Cluster Headache Patients in Case‐Control and Case‐Crossover Settings: A Systematic Review and Meta‐Analysis

  2020cites this paper
• From transformation to chronification of migraine: pathophysiological and clinical aspects

  2020cites this paper
• Two-hour infusion of vasoactive intestinal polypeptide induces delayed headache and extracranial vasodilation in healthy volunteers

  2020cites this paper
• Serum CGRP, VIP, and PACAP usefulness in migraine: a case–control study in chronic migraine patients in real clinical practice

  2020cites this paper
• How does the brain change in chronic migraine? Developing disease biomarkers

  2020cites this paper
• Síntomas parasimpáticos craneales en pacientes con migraña crónica y correlación con biomarcadores

  2020cites this paper
• Chronic Migraine

  2020cites this paper
• Calcitonin gene-related peptide in migraine: from pathophysiology to treatment.

  2019cites this paper
• Mechanisms of migraine as a chronic evolutive condition

  2019cites this paper
• Circulating Biomarkers In Migraine. New Opportunities For Precision Medicine.

  2019cites this paper
• Paranasal sinus air suction for immediate pain relief of acute migraine – a randomized, double blind pilot study

  2019cites this paper
• Effect of Electroacupuncture on Hyperalgesia and Vasoactive Neurotransmitters in a Rat Model of Conscious Recurrent Migraine

  2019cites this paper
• A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson’s Disease

  2019cites this paper
• Role of adipocytokines in the pathophysiology of migraine: A cross-sectional study

  2018cites this paper
• Therapie der chronischen Migräne mit Botulinumneurotoxin A

  2018influential citation
• Zwei Migränepatienten mit zyklischem Erbrechen

  2018cites this paper
• Quantitative sensory testing in migraine patients must be phase-specific.

  2018cites this paper
• Animal Models of Chronic Migraine

  2018cites this paper
• CGRP and PTX3 as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine: An Observational Study

  2018cites this paper
• Quantitative sensory testing in migraine patients must be phase-specific Letter to

  2018cites this paper
• Migraine and Autonomic Dysfunction: Which Is the Horse and Which Is the Jockey?

  2018cites this paper
• Perivascular neurotransmitters: Regulation of cerebral blood flow and role in primary headaches

  2017cites this paper
• Part II: Biochemical changes after pituitary adenylate cyclase-activating polypeptide-38 infusion in migraine patients

  2017cites this paper
• Spectral heart rate variability and selected biochemical markers for autonomic activity in rats under pentobarbital anesthesia

  2017cites this paper
• Calcitonin gene-related peptide in peripheral blood as a biomarker for migraine

  2017cites this paper
• Human models of migraine — short-term pain for long-term gain

  2017cites this paper
• Neuropeptides as a Marker for Chronic Headache

  2017cites this paper
• The role of genetics on migraine induction triggered by CGRP and PACAP38.

  2017cites this paper
• Migraine, Neurogenic Inflammation, Drug Development - Pharmacochemical Aspects.

  2017cites this paper
• Relationship between serum levels of VIP, but not of CGRP, and cranial autonomic parasympathetic symptoms: A study in chronic migraine patients

  2017cites this paper
• Diagnosis and treatmentMigraineMigraña

  2016cites this paper
• Transmission pathways and mediators as the basis for clinical pharmacology of pain

  2016cites this paper
• Chronic migraine: risk factors, mechanisms and treatment

  2016cites this paper
• Prevalence of cranial autonomic parasympathetic symptoms in chronic migraine: Usefulness of a new scale

  2016cites this paper
• Mass spectrometry-based characterization of cell-to-cell signaling molecules in the nervous system

  2016cites this paper
• Parasympathetic Cholinergic and Neuropeptide Mechanisms of Migraine

  2016influential citation
• Autonomous control of cardiovascular reactivity in patients with episodic and chronic forms of migraine

  2016cites this paper
• No Change in Interictal PACAP Levels in Peripheral Blood in Women With Chronic Migraine

  2016cites this paper
• OnabotulinumtoxinA for chronic migraine: a critical appraisal

  2015influential citation
• CGRP antibodies: the Holy Grail for migraine prevention?

  2015cites this paper
• Treatment of chronic migraine with transcutaneous stimulation of the auricular branch of the vagal nerve (auricular t-VNS): a randomized, monocentric clinical trial

  2015cites this paper
• Aalborg Universitet Treatment of chronic migraine with transcutaneous stimulation of the auricular branch of the vagal nerve ( auricular t-VNS )

  2015cites this paper
• Biochemistry of Primary Headaches

  2015cites this paper
• New Insights into Diagnostic Biomarkers of Migraine: Biological, Genetic and Radiological

  2015influential citation
• CGRP and VIP Levels as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine

  2014cites this paper